ReadTheTrial — Clinical Trial Data in Plain English

Understand any clinical trial in plain English. AI-powered analysis of ClinicalTrials.gov data with decoded eligibility, outcomes, and expert summaries for patients, researchers, and investors.

Recent Clinical Trials

Genetic Ablation of CD33 in Hematopoietic Stem Cells to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with Acute Myeloid Leukemia (AML)

NCT05662904 · NOT YET RECRUITING · Phase 1 · German Cancer Research Center

Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function

NCT07430332 · NOT YET RECRUITING · Phase 2 · Children's Hospital Medical Center, Cincinnati

A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects With Severe Sickle Cell Disease, βS/βC Genotype

NCT05951205 · WITHDRAWN · Phase 3 · Vertex Pharmaceuticals Incorporated

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Prospective, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Administration of GV1001 1.12 mg/Day in Patients With Moderate to Severe Alzheimer Disease

NCT05303701 · NOT YET RECRUITING · Phase 3 · Samsung Pharmaceutical Co., Ltd.

Human Models of Selective Insulin Resistance: Pancreatic Clamp

NCT06558422 · NOT YET RECRUITING · Phase 1 · Columbia University

Low-dose Versus Standard-dose Anticoagulation With Argatroban and Enoxaparin During Extracorporeal Membrane Oxygenation Controlled by Anti-IIa and An-ti-Xa, Respectively

NCT07499037 · NOT YET RECRUITING · Phase 2 · University Hospital Ostrava

Sitagliptin's Effects on Glucose-stimulated Insulin Secretion and Oral Glucose

NCT06813014 · NOT YET RECRUITING · Phase 4 · University of Maryland, Baltimore

Neoadjuvant Chemotherapy With or Without Cemiplimab (REGN2810) in Sinonasal Squamous Cell Carcinoma: A Randomized Phase 2 Study

NCT07281417 · RECRUITING · Phase 2 · National Cancer Institute (NCI)

A Phase 3 Study With an Open-Label Extension in Pediatric Participants to Evaluate the Safety, Efficacy, and Pharmacokinetics of Diroximel Fumarate and Dimethyl Fumarate for the Treatment of Relapsing Forms of Multiple Sclerosis

NCT07483632 · NOT YET RECRUITING · Phase 3 · Biogen

Improving Safety of Cardiovascular Implantable Electronic Devices in Veterans (CDA 21-057)

NCT05062434 · NOT YET RECRUITING · N/A · VA Office of Research and Development

A Phase II Randomized Trial of Neoadjuvant Chemotherapy or Chemo-Immunotherapy in Patients With Recurrent/Persistent PD-L1 Enriched Squamous Cell Carcinoma of the Head and Neck Undergoing Salvage Surgery (NEOPOLIS)

NCT07195734 · RECRUITING · Phase 2 · National Cancer Institute (NCI)

Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors

NCT07137416 · RECRUITING · Phase 1 · National Cancer Institute (NCI)

The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

NCT06972407 · NOT YET RECRUITING · Phase 2 · Mayo Clinic

Investigation of the Effectiveness of Foot Core Exercise Training With Telerehabilitation in Individuals With Rheumatoid Arthritis: A Randomized Controlled Single-Blind Study

NCT06667856 · SUSPENDED · N/A · Pamukkale University

Multicenter Randomised Controlled Trial: Benefit of Intra-pocket Echo-guided Axillary Puncture Compared With Percutaneous Echo-guided Axillary Puncture and Cephalic Vein Dissection for the Primary Implantation of Intracardiac Electronic Devices.

NCT07273929 · NOT YET RECRUITING · Phase 3 · Hospices Civils de Lyon

Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder

NCT06532604 · NOT YET RECRUITING · N/A · Centre Psychothérapique de Nancy

PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

NCT06452290 · NOT YET RECRUITING · N/A · Central Hospital, Nancy, France

Autoimmune Thyroid Disease Patients Identification and Assessment of Pancreatic Islet Autoimmune Risk

NCT07494474 · NOT YET RECRUITING · N/A · Nanjing Medical University

A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery

NCT06980038 · RECRUITING · Phase 2 · National Cancer Institute (NCI)

A Phase I/II Study Evaluating the Safety, Tolerability, and Efficacy of Sotorasib Plus Trastuzumab Deruxtecan in Patients With Advanced Non-Small Cell Lung Cancer With a KRASG12C Mutation

NCT07012031 · RECRUITING · Phase 2 · National Cancer Institute (NCI)

Explore